• Language: English
    • Italiano Italiano
    • English English

CNCCS

MENU
  • Home
  • Chemical Compounds
    • Compound Collection
    • Our Laboratories
  • Centre for rare diseases
    • Research Areas
    • Rare Diseases
    • Neglected and Poverty Diseases
  • Bioeconomy
    • Edition 2014
    • Edition 2013
    • Edition 2012
    • Edition 2011
  • Media
    • Press Review
    • videos
    • Video Gallery
  • Policies and Certifications
  • Contact Us
    • Job Opportunities
piero di lorenzo

(Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus

30 June 2016 Comments Off on (Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus news  Like

Sorry, this entry is only available in Italian.

 Like news (Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus

About the Author: cnccs

Comments are closed.

Recent Posts

  • (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • (Italiano) Interview with Matteo Liguori. Research needs time
  • (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people
  • (Italiano) Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed»
  • (Italiano) IRBM Pomezia confirms first vaccine doses may arrive in Dec

Contact Us

Fax: +39.06.91093654
Mail: info@cnccs

CNCCS Scarl
Collection of National Chemical Compounds and Screening Center
Via Pontina km 30,600 – 00040 Pomezia (RM)

News

  • (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%»
  • (Italiano) Interview with Matteo Liguori. Research needs time
  • (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people
  • (Italiano) Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed»

Partners